Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Glabellar Frown Lines”

44 trials

Showing 20 of 44 results

Testing effectiveness (Phase 2)Study completedNCT04996810
What this trial is testing

The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 60
Post-approval studies (Phase 4)Study completedNCT03687736
What this trial is testing

Subject Satisfaction With AbobutulinumtoxinA Treatment

Who this might be right for
Glabellar Frown Lines
Galderma R&D 120
Large-scale testing (Phase 3)Study completedNCT03960957
What this trial is testing

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 301
Testing effectiveness (Phase 2)Study completedNCT02184988
What this trial is testing

Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 352
Very early researchUnknownNCT05305768
What this trial is testing

Xeomin Treatment of Glabellar Lines Using OLD Versus COLD

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Large-scale testing (Phase 3)UnknownNCT03440671
What this trial is testing

The Safety and Efficacy Study of Hutox Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Huons Co., Ltd. 260
Testing effectiveness (Phase 2)Study completedNCT05217355
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 50
Testing effectiveness (Phase 2)Study completedNCT02428608
What this trial is testing

Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 570
Post-approval studies (Phase 4)Study completedNCT01391312
What this trial is testing

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Who this might be right for
Glabellar Frown Lines
Allergan 40
Testing effectiveness (Phase 2)Study completedNCT01485601
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medy-Tox 121
Large-scale testing (Phase 3)Study completedNCT06946160
What this trial is testing

A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar LinesGlabellar Frown Lines
Espad Pharmed 146
Large-scale testing (Phase 3)Study completedNCT05364580
What this trial is testing

The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 269
Large-scale testing (Phase 3)Study completedNCT06585696
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)

Who this might be right for
Glabellar Frown Lines
Cutia Therapeutics（Wuxi）Co.,Ltd 554
Large-scale testing (Phase 3)Study completedNCT04247074
What this trial is testing

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

Who this might be right for
Glabellar Frown Lines (GL)Lateral Canthal Lines (LCL)
Galderma R&D 413
Large-scale testing (Phase 3)Study completedNCT00770211
What this trial is testing

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines

Who this might be right for
Moderate to Severe Glabellar Frown Lines
Merz Pharmaceuticals GmbH 271
Testing effectiveness (Phase 2)Study completedNCT01333397
What this trial is testing

Safety and Efficacy Study of Dysport RU and Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Ipsen 176
Large-scale testing (Phase 3)Study completedNCT02334423
What this trial is testing

A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 330
Post-approval studies (Phase 4)Study completedNCT02568150
What this trial is testing

Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines

Who this might be right for
Moderate-severe Glabellar Lines
Daewoong Pharmaceutical Co. LTD. 45
Large-scale testing (Phase 3)Study completedNCT05146999
What this trial is testing

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 132
Large-scale testing (Phase 3)Study completedNCT06124794
What this trial is testing

The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 155
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation